Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose metronidazole with lactic acid for bacterial vaginosis in Thai women
TCTR20231106004Phase 4Completed
- Sponsor
- Bayer
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bacterial vaginosis (BV) comparing Single-dose metronidazole alone with Single-dose metronidazole plus lactic acid (2 arms). Started Nov 2023; status: completed.
02
Drugs
metronidazolelactic acid
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on TCTR20231106004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231106004.